Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: WE PHARMA, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2020-09-30 to 2021-09-29
Current total value of award: $169918.01
Description: THE PURPOSE AND OBJECTIVES OF THIS REQUIREMENT IS TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.